Cubist Pharmaceuticals, Inc. (NASDAQ:CBST)

CAPS Rating: 4 out of 5

A biopharmaceutical company focused on the research, development and commercialization of pharmaceutical products that address unmet medical needs in the acute care environment.

Recs

0
Player Avatar gonelong (32.66) Submitted: 1/24/2011 3:27:26 PM : Outperform Start Price: $22.46 CBST Score: +75.07

MP(sp)

Featured Broker Partners


Advertisement